IRLAB Therapeutics AB (publ) (FRA:6IRA)

Germany · Delayed Price · Currency is EUR

0.1650

+0.0026 (1.60%)

Last updated: Feb 23, 2026, 8:04 AM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	94.63M	5.68M	61.14M	207.78M	300.00K
Pharmaceuticals Growth	1566.57%	-90.71%	-70.58%	69160.67%	-19.35%
Total	94.63M	5.68M	61.14M	207.78M	300.00K
Total Growth	1566.57%	-90.71%	-70.58%	69160.67%	-19.35%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	94.63M	4.22M	-	-	-
United States Growth	2142.37%	-	-	-	-
United Kingdom	-	1.46M	61.14M	207.78M	-
United Kingdom Growth	-	-97.62%	-70.58%	-	-
Total	94.63M	5.68M	61.14M	207.78M	-
Total Growth	1566.57%	-90.71%	-70.58%	-	-

Source: S&P Global Market Intelligence.